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<: Serial Number 
UNIVERSITY OF RHODE ISLAND 
Kingston, Rhode Island 
FACULTY SENATE 
BILL 
Adopted by the Faculty Senate 
#97-98--26 
TO: President Robert L. Carothers 
FROM: Chairperson of the Faculty Senate 
1. The attached BILL, titled The Three Hundred and Sixtieth Report 
of the Curricular Affairs Committee: Proposal for the 6-year 
Doctor of Pharmacy Degree 
is forwarded for your consideration. 
2. The original and two copies for your use are included. 
3. This BILL was adopted by vote of the Faculty Senate on 
1998. 
April 23, 
4. After considering this bill, will you please indicate your approval 
or disapproval. Return the original or forward it to the Board of 
Governors, completing the appropriate endorsement below. 
5. In accordance with Section 10, paragraph 4 of the Senate's By-Laws, 
this bill will become effective May 14, 1998 , three weeks 
after Senate approval, unless: (1) specific dates for implementation 
are written into the bill; (2) you return it disapproved; (3) you 
forward it to the Board of Governors for their approval; or (4) the 
University Faculty petitions for a referendum. If the bill is 
forwarded to the Board of Governors, it will not become effective 
until approved by the Board. 
April 24, 1998 
(date) eland Jackson 
of the Faculty Senate 
ENDORSEMENT 
TO: Chairperson of the Faculty Senate 
FROM: President of the University 
Returned. 
a. Approved ~-
b. Approved subject to final approval by Board of Governors ~· . 
c. Disapproved 
( dat:e) 
Form revised 9/91 
UNIVERSITY OF RHODE ISLAND 
Kingston, Rhode Island 
FACULTY SENATE 
Faculty Senate Curricular Affairs Committee 
Three Hundred and Sixtieth Report 
March 31, 1998 
Proposal to Establish the 6-Year Doctor of Pharmacy Degree Program 
As the Sole Professional Degree Offered by the 
College of Pharmacy 
At its meeting of March 30, 1998, the Curricular Affairs Committee 
considered the proposal from the College of Pharmacy that begining 
with students entering in the fall 1998 all students will follow a 6-
year curriculum for a degree of Pharm.D. which replaces the 5-year 
Bachelors degree in Pharmacy and the existing 6-year Pharm.D. option. 
The proposal is now presented to the Faculty Senate. 
S E C T I 0 N I 
Background and Rationale 
National professional standards for the practice of pharmacy have 
changed over the past years. The American Council of Pharmaceutical 
Education voted in 1996 that the Doctor of Pharmacy degree should be 
the sole entry-level degree for the profession of pharmacy. The 
University of Rhode Island College of Pharmacy voted in the fall of 
1996 to phase out the Bachelor of Science degree in Pharmacy and 
convert to an entry-level Doctor of Pharmacy degree with the freshman 
class entering in the fall of 1998. currently, the College offers the 
5-year B.S. degree and a track-in 6-year Doctor of Pharmacy degree 
(students in the 4th year of the B.S. program apply for transfer into 
the Pharm.D. program for their 5th and 6th years). 
The following course deletions and additions represent a substantial 
change in the professional curriculum years three through six for 
students desiring to earn a pharmacy degree and thus to qualify to 
practice pharmacy in Rhode Island and elsewhere. The College of 
Pharmacy has worked over the past 18 months to create a new program of 
study -- one that incorporates the new professional standards for 
pharmacists, is integrated across disciplines in core areas of study, 
provides space for professional electives, increases interactive 
learning, provides skills to encourage self-instruction to promote 
life-long learning, and meets accreditation standards for the practice 
of pharmacy. 
This proposed curriculum: 
o meets all American Council of Pharmaceutical Education competency 
standards for the year 2000; 
o integrates complementary pharmacy courses by organ system (e.g. 
the diseases of the central nervous system; and the pharmacology, 
medicinal chemistry, and pharmacotherapeutics of drugs useful in 
the treatment of these diseases are taught in the same semester) ; 
o allows space for the student to elect professional coursework in 
an area, or 'track', based on student interest; 
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o uses interactive learning methods in small groups designed to 
enhance communication and problem solving skills; 
o streamlines required credits by eliminating two-tier didactic and 
clincical courses which were previously needed for the two degree 
programs, and 
o through integration of coursework, avoids requiring students to 
enroll in 18 and 19 credit semesters. 
S E C T I 0 N II 
Matters Which Require Confirmation by the Faculty Senate. 
A. ADD: The following courses to be offered beginning in year 3 
(2000-2001): 
1. Applied Pharmaceutical Sciences 
a. APS 314 Physical Pharmacy and Pharmaceutical 
Calculations (I, 3) Physicochemical properties of 
drug molecules, and their effect on formulation 
and manufacturing of various dosage forms. An 
emphasis on necessary pharmaceutical calculations. 
(Lec.3) Pre: third year standing or permission 
of instructor. Zia 
b. APS 315 Biopharmaceutics (I, 2) Applications of 
kinetics to dissolution, absorption, and other 
biopharmaceutical processes. Bioavailability and 
generic equivalence. Regulatory aspects of 
biopharmaceutics including special populations. 
(Lee. 2) Pre: third year standing or permission 
of instructor. Rhodes 
c. APS 316 Pharmacy Law and Ethics (I, 3) Basic 
principles of law and ethics as applied to 
federal, state and local acts, regulation, and 
practices encountered in professional practice. 
Specific attention to liabilities of pharmacists 
in decisions; actions involving sale of 
medicinals, poisons, narcotics. (Lee. 3) Pre: 
third year standing or permission of instructor. 
Campbell 
d. APS 318 Pharmacy Technology Laboratory (I, 1) 
Prescription processing and compounding techniques 
for pharmaceutical dosage forms. (Lab. 3) Pre: 
third year standing or permission of instructor. 
Zia 
e. APS 324 Pharmaceutical Technology (II, 3) A review 
of the methods of manufacture of and eval uation of 
drug delivery systems. (Lee. 3) Pre: third year 
standing or permission of instructor. Kislalioglu 
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f. APS 403 Pharmacokinetics I (I, 3) Pharmacokinetics 
of drug distribution, metabolism, and elimination. 
Compartmental models, pharmacokinetic modeling, 
development of dosage regimens. (Lee. 3) Pre: 
fourth year standing or permission of instructor. 
Rosenbaum 
g. APS 503 Health Systems I (I, 2) Introduction to 
the principles of financial analysis, personal 
management, organizational behavior, inventory 
control, and health policy. Principles as they 
relate to healthcare delivery with an emphasis on 
planning systems. (Lee. 2) Pre: fifth year 
standing or permission of instructor. Staff 
h. APS 504 Health Systems II (II, 3) Analysis and 
interpretation of the health care delivery system 
from the perspectives of organizational structure 
and program analysis. Emphasis on 
pharmacoeconomic aspects of quality of life 
issues, outcome measurements, reimbursement 
systems and drug utilization evaluation. (Lee. 3) 
Pre: fifth year standing or permission of 
instructor. Staff 
2. Biomedical Sciences 
a. BMS 325 Principles of Drug Analysis (II, 2) 
Competency in understanding the molecular basis of 
drug analysis: neutralization, 
oxidation/reduction, enzymatic reactions, 
clinically relevant spectroscopic and 
chromatographic techniques. (Lee. 2) Pre: third 
year standing or permission of instructor. Cho 
b. BMS 313 Introduction to Medicinal Chemistry and 
Drug Metabolism (I,2) Basic chemical knowledge for 
understanding drug-receptor interaction, 
biotransformation of drugs [Phase I (oxidation, 
reduct i on, hydrolysis) and Phase II (conjugation, 
addition) metabolism], and prodrug concept. (Lee. 
2) Pre: third year standing or permission of 
instructor. Cho, Panzica 
c. BMS 321 Principles of Pharmacology and Autonomic 
Pharmacology (I,2) Fundamental principles of drug 
action with emphasis on drug/receptor 
interactions. Mechanisms of action and medicinal 
chemistry of drugs that affect the autonomic 
nervous system. (Lee. 2) Pre: third year 
standing or permission of instructor. Babson, 
Panzica and Rodgers 
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d. BMS 322 Pharmacology and Medicinal Chemistry of 
Drugs Acting on the Central Nervous System (II,2) 
Neurologic agents in the brain; antidepressants, 
antipsychotics, sedative hypnotics, analgesics, 
anti-seizure medications, anti-dementia therapy, 
and anti-anxiety medications. (Lee. 2) Pre: 
third year standing or permission of instructor. 
Swonger 
e. BMS 326 Pharmacology and Medicinal Chemistry 
Laboratory I (II, 1) Effects of drugs on 
physiological functions. Identification and 
quantification of drugs and their actions. (Lab. 
3) Pre: third year standing or permission of 
instructor. Chichester, Cho and Staff 
f. BMS 416 Pharmacology and Medicinal Chemistry 
Laboratory II (I, 1) Pharmacologic principles 
relating to the modification of drug activity and 
toxicity. Clinical assays relevant to assessing 
drug effects. (Lab. 3) Pre: fourth year standing 
or permission of instructor. Yan, Martin and 
Staff 
g. BMS 421 Pharmacology and Medicinal Chemistry of 
Anti-infective and Respiratory Agents (I, 2) 
Chemistry, mechanism of action, sensitivity, 
resistance and toxicity of anti-infections drugs, 
and an overview of antibacterial, antifungal, 
antiviral, antiprotozoal, respiratory drugs and 
vaccines in current use. (Lee. 2) Pre: fourth 
year standing or permission of instructor. Staff 
h. BMS 422 Endocrine, Gastrointestional and 
Biotechnologic Drugs (II, 2) Mechanisms of action 
of drugs used to treat endocrine and 
gastrointestional disorders. Biological and 
biotechnologic sources, isolation, design and 
medicinal chemistry of biopolymer drugs. (Lee. 2) 
Pre: fourth year standing or permission of 
instructor. Babson and Martin 
i. BMS 521 Cancer Chemotherapy and Toxicology (I, 2) 
Pharmacology and medicinal chemistry of oncology 
drugs. Principles of toxicology. (Lee. 2) Pre: 
fifth year standing or permission of instructor. 
Chichester, Panzica and Shaikh 
j. BMS 522 Pharmacology and Medicinal Chemistry of 
Cardiovascular and Renal Drugs (II, 2) Mechanism 
of action, adverse effects and therapeutic 
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applications of drugs affecting cardiovascular and 
renal function. (Lee. 2) Pre: fifth year 
standing or permission of instructor. Rodgers 
3. Biomedical Sciences and Pharmacy Practice 
a. BMS 311 (or PHP 311) Foundations of Human Disease 
I: Immunoinflammatory Disease (I, 2) The 
pathogenesis, etiology, epidemiology, symptomatol-
ogy, and diagnosis of immunoinflammatory and 
musculo-skeletal diseases. The pharmacology and 
medicinal chemistry of anti-inflammatory 
medications, immunosuppressives, and 
anti-rheumatic drugs. (Lee. 2) Pre: third year 
standing or permission of instructor. Chichester, 
Panzica, Martin, Owens 
b. BMS 312 (or PHP 312) Foundations of Human Disease 
II: Central Nervous System Disease (II, 2) The 
etiology, pathogenesis, epidemiology, symptomatol-
ogy, and diagnosis of diseases of the central 
nervous system. (Lee. 2) Swonger, Owens 
c. BMS 411 (or PHP 411) Foundations o.f Human Disease 
III: Infectious and Pulmonary Processes (I, 2) 
The etiology, pathogenesis, epidemiology, 
symptomatology, and diagnosis of infections and 
pulmonary diseases. (Lee. 2) Pre: fourth year 
standing or permission of instructor. Geletko, 
Shimizu 
d. BMS 412 (or PHP 412) Foundations of Human Disease 
IV: Endocrinology, Oncology, Medicinal Genetics, 
GI (II, 3) The etiology, pathogenesis, 
symptomatology, and disgnosis of diseases of 
endocrine, oncologic, and genetic origin. (Lee. 
3) Pre: fourth year standing or permission of 
instructor. Yan, Glen 
e. BMS 512 (or PHP 512) Foundations of Human Disease 
V: Renal and Cardiovascular Diseases (II, 2) The 
etiology, pathogenesis, epidemiology, and 
symptomatology, and diagnosis of renal and 
cardiovascular diseases. (Lee. 2) Pre: fifth year 
standing or permission of instructor. Barbour 
Rodgers 
f. BMS 518 (or PHP 518) Self-Care I (I, 3) An 
overview of alternative therapies with an emphasis 
on self-care and natural medicine alternatives. 
Basic information as well as case studies. (Lee. 
3) Pre: fifth year standing or permission of 
instructor. Staff 
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4. Pharmacy Practice 
a. PHP 324 Pharmacotherapy of CNS and Musculo-
skeletal Disorders - Therapeutics I (II, 2) The 
appropriate use of medications in the treatment of 
human disease. Interpretation of clinical data to 
design, monitor, and modify drug therapy in 
psychiatric, neurologic, and musculo-skeletal 
diseases. (Lee. 2) Pre: third year standing or 
permission of instructor. Dufresne 
b. PHP 413 Pharmacotherapy of Infectious Diseases -
Therapeutics II (I, 2) The appropriate use of 
medications in the treatment of human disease. 
Interpretation of clinical data to design, 
monitor, and modify drug therapy in infection and 
pulmonary disease. (Lee. 2) Pre: fourth year 
standing or permission of instructor. Rana 
c. PHP 414 Pharmacotherapy of Endocrine and GI 
Disorders - Therapeutics III (II, 2) The 
appropriate use of medicatons in the treatment of 
human disease. Interpretation of clinical data to 
design, monitor, and modify drug therapy in 
endocrine and gastrointestinal disease. (Lee. 2) 
Pre: fourth year standing or permission of 
instructor. Luisi 
d. PHP 513 Pharmacotherapy of Oncology and Toxicology 
- Therapeutics IV (I, 2) The appropriate use of 
medications in the treatment of human disease. 
Interpretation of clinical data to design, 
monitor, and modify drug therapy in cancer, blood 
disorders, and overdose conditions. (Lee. 2) Pre: 
fifth year standing or permission of instructor. 
Glen 
e. PHP 514 Pharmacotherapy of Renal and 
Cardiovascular Disorders - Therapeutics V (II, 2) 
The appropriate use of medications in the 
treatment of human disease. Interpretation of 
clinical data to design, monitor, and modify drug 
therapy in renal and cardiovascular disease. 
(Lee. 2) Pre: fifth year standing or permission 
of instructor. Hume 
f. PHP 591 Clinical Clerkship (I and II, 7) Through 
direct clinical contact, students will learn how 
to provide optimal pharmaceutical care for 
patients. Students will collect and interpret 
data to design, recommend, implement, and modify 
patient-specific pharmacotherapy in collaboration 
with other health care professionals. (Practicum 
7.5 wks) Pre: sixth year standing. Geletko and 
Staff 
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g. PHP 592 Clinical Clerkship (I and II, 7) Through 
direct clinical contact, studentsQ~~l learn how 
to provide optimal pharmaceuticall\fohatients. 
students will collect and interpret data to 
design, recommend, implement, and modify 
patient-specific pharmacotherapy in collaboration 
with other heal th care professionals. (Practicum 
7.5 wks) Pre: sixth year standing. Geletko and 
Staff 
h. PHP 593 Clinical Clerkship (I and II, 7) Through 
direct clinical contact, students will learn how 
to provide optimal pharmaceutical care for 
patients. Students will collect and interpret 
data to design, recommend, implement, and modify 
patient-specifi c pharmacotherapy in collaboration 
with other health care professionals. (Practicum 
7.5 wks) Pre: sixth year standing. Geletko and 
Staff 
5. Pharmacy 
a. PHC 317 Interactive Learning Session I (I, 1) 
Small group active learning sessions designed to 
progressively reinforce the basic science 
curriculum, promote communication and 
problem-solving skills, and enhance patient 
assessment and the delivery of pharmaceutical 
care. (Seminar 1) Pre: third year standing or 
permission of instructor. Staff 
b. PHC 327 Interactive Learning Session II (II, 1) 
Small goup active learning designed to 
progressively reinforce the basic science 
curriculum, promote communication and 
problem-solving skills, and enhance patient 
assessment and the delivery of pharmaceutical 
care. (Seminar 1) Pre: third year standing or 
permission of instructor. Staff 
c. PHC 417 Interactive Learning Session III (I, 1) 
Small group active learning designed to 
progressively reinforce the basic science 
curriculum, promote communication and 
problem-solving skills, and enhance patient 
assessment and the delivery of pharmaceutical 
care. (Seminar 1) Pre: fourth year standing or 
permission of instructor. Staff 
d. PHC 427 Interactive Learning Session IV (II, 1) 
Small group active learning designed to 
progressively reinforce the basic II 8 science 
curriculum, promote communication and 
problem-solving skills, enhance patient assessment 
and the delivery of pharmaceutical care. (Seminar 
1) Pre: fourth year standing or permission of 
instructor. Staff 
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e. PHC 517 Interactive Learning Session V (I, 1) 
Small group active learning designed to 
progressively reinforce the basic science 
curriculum, promote communication and 
problem-solving skills, and enhance patient 
assessment and the delivery of pharmaceutical 
care. (Seminar 1) Pre: fifth year standing or 
permission of instructor. Staff 
f. PHC 527 Interactive Learning Session VI (II, 1) 
Small group active learning designed to 
progressively reinforce the basic science 
curriculum, promote communication and 
problem-solving skills, and enhance patient 
assessment and the delivery of pharmaceutical 
care. (Seminar 1) Pre: fifth year standing or 
permission of instructor. Staff 
g. PHC 594 Experiential Tracking Practicum (I and II, 
7) Through direct hands-on work, students will 
learn how to acquire, interpret, and apply 
information to extend their knowledge in a 
specific field. This will be accomplished by 
collaborative work with a faculty sponsor. 
(Practicum 7.5 wks) Pre: sixth year standing. 
Staff 
6. Applied Pharmaceutical Sciences and Pharmacy Practice 
a. APS 404 (or PHP 404) Pharmacokinetics II (II, 3) 
Applied pharmacokinetics; therapeutic drug 
monitoring, individualization of doses. (Lee. 3) 
Pre: fourth year standing or permission of 
instructor. Rosenbaum and McKindley 
b. APS 515 (or PHP 515) Pharmacy Practice Laboratory 
I (I, 1) Simulated practice sessions designed to 
develop the delivery of pharmaceutical care, 
including prescription processing, use of patient 
profiles, communication with patients and health 
care professionals, pharmaco-epidemiology, and 
physical assessment. (Lab. 3) Pre: fifth year 
standing or permission of instructor. Cyganoski 
c. APS 516 (or PHP 516) Pharmacy Practice Laboratory 
II (II, 1) Simulated practice sessions designed to 
develop the delivery of pharmaceutical care, 
including prescription pnGcessing, use of patient 
profiles, communication with patients and health 
ere professionals, pharmaco-epidemiology, and 
physical assessment. (Lab. 3) Pre: fifth year 
standing or permission of instructor. Cyganoski 
d. APS 411 (or ~HP 411 or STA 411) Biostatistics II 
(I, 3) An overview of statistical methods used in 
performing research in pharmacotherapeutics and 
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pharmaco-epidemiology. Emphasis on understanding 
both common study designs, and the output from 
statistical analysis of data obtained from these 
studies. (Lee. 3) Pre: fourth year standing or 
permission of instructor. Dufresne, Heltshe, and 
Staff 
B. Delete the following courses: 
1) Department of Applied Pharmaceutical Sciences 
a) 
b) 
c) 
d) 
e) 
f) 
g) 
h) 
i) 
j) 
k) 
APS 327 last offered fall 1999 
APS 328 last offered spring 2000 
APS 340 last offered spring 2000 
APS 349 last offered fall 1999 
APS 350 last offered fall 1999 
APS 351 last offered spring 2000 
APS 360 last offered spring 2000 
APS 448 last offered spring 2001 
APS 459 last offered fall 2000 
APS 461 last offered fall 2001 
APS 462 last offered fall 2001 
2) Department of Biomedical Sciences 
a) BMS 327 last offered fall 1999 
b) BMS 342 last offered spring 2000 
c) BMS 343 last offered fall 1999 
d) BMS 443 last offered fall 2000 
e) BMS 444 last offered spring 2001 
f) BMS 446 last offered fall 2000 
g) BMS 451 last offered spring 2001 
h) BMS 454 last offered spring 2000 
i) BMS 455 last offered fall 2000 
j) BMS 456 last offered spring 2001 
3) Department of Pharmacy Practice 
a) PHP 455 last offered fall 2000 
b) PHP 456 last offered spring 2001 
c) PHP 471 last offered fall 2001 
d) PHP 484 last offered spring 2002 
e) PHP 485 last offered spring 2002 
f) PHP 490 last offered spring 2002 
C. Change Curriculum for the Third, Fourth, Fifth and Sixth years: 
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Third Year Fall credits Third Year Spring credits 
Foundations Human Dis I PHP!BMS 311 2 Foundations Human Dis II PHP!BMS 2 
312 
Principles of Pharmcol. BMS 321 2 BMS neuro psych BMS 322 2 
Intro to Med Chemistry BMS 313 2 Pharmacotherapeutics I PHP 324 2 
Physical Pharmacy APS 314 3 Pharmaceutical Technology APS 324 3 
Biopharmaceutics APS 315 2 Pharmaceutical Analysis BMS 325 2 
Law&Ethics APS 316 3 
Pharmacy Technology lab APS 318 MCMIPCOL lab BMS 326 
Interactive Learning * PHC 317 Interactive Learning * PHC 327 
university elective 3 
16 16 
Fourth Year Fall credits Fourth Year Spring credits 
Found. of Human Disease III PHP/BMS 2 Found. of Human Disease IV PHP/BMS 3 
.~:· 411 412 
BMS antiinfectives, pulm BMS 421 2 BMS endo, GI, biotech BMS 422 2 
Pharmacotherapeutics II PHP 413 2 Pharmacotherapeutics III PHP 414 2 
Pharmacokinetics I APS 403 3 Pharmacokinetics II APS 404 3 
Statistics APS!PHP/STA411 3 professional tracking 3 
MCH/PCOL lab BMS 416 
Interactive Learning • PHC 417 Interactive Learning * PHC 427 
14 14 
Fifth Year Fall credits Fifth Year Spring credits 
Found. of Human Disease VI PHP/BMS 2 
512 
BMS oncology, tox BMS 521 2 BMS cardio, renal BMS 522 2 
Pharmacotherapeutics IV PHP 513 2 Pharmacotherapeutics V PHP 514 2 
Health Systems I APS 503 2 Health Systems II APS 504 3 
Self Care I BMS/PHP 518 3 Nutr in Health & Disease FSN 444 3 
professional tracking 6 professional tracking 3 
Practice Lab PHP 515 Practice Lab PHP 516 
Interactive Learning * PHC 517 Interactive Learning * PHC 527 
17 17 
Interactive learning courses will be shared by PHP, BMS, and APS 
Sixth Year Fall and Spring 
21 credits ofPHP 591, PHP 592, and PHP 593- clinical clerkships (7 credits each) 
7 credits of tracking experiential practicum in PHC 594 
Total credits required for graduation: 188 
